In medicine, compliance (also adherence, capacitance) describes the degree to which a patient correctly follows medical advice. Most commonly, it refers to medication or drug compliance, but it can also apply to other situations such as medical device use, self care, self-directed exercises, or therapy sessions. Both the patient and the health-care provider affect compliance, and a positive physician-patient relationship is the most important factor in improving compliance, although the high cost of prescription medication also plays a major role.
Scope of the Report:
This report focuses on the Medication Adherence in Global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
Novartis
Pfizer
Roche
Sanofi
Merck & Co.
Johnson & Johnson
GlaxoSmithKline
AstraZeneca
Gilead Sciences
Takeda
AbbVie
Amgen
Teva
Lilly
Bristol-Myers Squibb
Bayer
Novo Nordisk
Astellas
Boehringer Ingelheim
Actavis
Market Segment by Regions, regional analysis covers
North America (USA, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Columbia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Cardiovascular Medication Adherence
CNS Medication Adherence
Diabetes Medication Adherence
Other
Market Segment by Applications, can be divided into
There are 15 Chapters to deeply display the global Medication Adherence market.
Chapter 1, to describe Medication Adherence Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Medication Adherence, with sales, revenue, and price of Medication Adherence, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Medication Adherence, for each region, from 2012 to 2017;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2012 to 2017;
Chapter 12, Medication Adherence market forecast, by regions, type and application, with sales and revenue, from 2017 to 2022;
Chapter 13, 14 and 15, to describe Medication Adherence sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
Table of Contents
1 Market Overview
1.1 Medication Adherence Introduction
1.2 Market Analysis by Type
1.2.1 Cardiovascular Medication Adherence
1.2.2 CNS Medication Adherence
1.2.3 Diabetes Medication Adherence
1.2.4 Other
1.3 Market Analysis by Applications
1.4 Market Analysis by Regions
1.4.1 North America (USA, Canada and Mexico)
1.4.1.1 USA Market States and Outlook (2012-2022)
1.4.1.2 Canada Market States and Outlook (2012-2022)
1.4.1.3 Mexico Market States and Outlook (2012-2022)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2012-2022)
1.4.2.2 France Market States and Outlook (2012-2022)
1.4.2.3 UK Market States and Outlook (2012-2022)
1.4.2.4 Russia Market States and Outlook (2012-2022)
1.4.2.5 Italy Market States and Outlook (2012-2022)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2012-2022)
1.4.3.2 Japan Market States and Outlook (2012-2022)
1.4.3.3 Korea Market States and Outlook (2012-2022)
1.4.3.4 India Market States and Outlook (2012-2022)
1.4.3.5 Southeast Asia Market States and Outlook (2012-2022)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2012-2022)
1.4.4.2 Egypt Market States and Outlook (2012-2022)
1.4.4.3 Saudi Arabia Market States and Outlook (2012-2022)
1.4.4.4 South Africa Market States and Outlook (2012-2022)
1.4.4.5 Nigeria Market States and Outlook (2012-2022)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Novartis
2.1.1 Business Overview
2.1.2 Medication Adherence Type and Applications
2.1.2.1 Type 1
2.1.2.2 Type 2
2.1.3 Novartis Medication Adherence Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Pfizer
2.2.1 Business Overview
2.2.2 Medication Adherence Type and Applications
2.2.2.1 Type 1
2.2.2.2 Type 2
2.2.3 Pfizer Medication Adherence Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Roche
2.3.1 Business Overview
2.3.2 Medication Adherence Type and Applications
2.3.2.1 Type 1
2.3.2.2 Type 2
2.3.3 Roche Medication Adherence Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Sanofi
2.4.1 Business Overview
2.4.2 Medication Adherence Type and Applications
2.4.2.1 Type 1
2.4.2.2 Type 2
2.4.3 Sanofi Medication Adherence Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Merck & Co.
2.5.1 Business Overview
2.5.2 Medication Adherence Type and Applications
2.5.2.1 Type 1
2.5.2.2 Type 2
2.5.3 Merck & Co. Medication Adherence Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Johnson & Johnson
2.6.1 Business Overview
2.6.2 Medication Adherence Type and Applications
2.6.2.1 Type 1
2.6.2.2 Type 2
2.6.3 Johnson & Johnson Medication Adherence Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 GlaxoSmithKline
2.7.1 Business Overview
2.7.2 Medication Adherence Type and Applications
2.7.2.1 Type 1
2.7.2.2 Type 2
2.7.3 GlaxoSmithKline Medication Adherence Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 AstraZeneca
2.8.1 Business Overview
2.8.2 Medication Adherence Type and Applications
2.8.2.1 Type 1
2.8.2.2 Type 2
2.8.3 AstraZeneca Medication Adherence Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 Gilead Sciences
2.9.1 Business Overview
2.9.2 Medication Adherence Type and Applications
2.9.2.1 Type 1
2.9.2.2 Type 2
2.9.3 Gilead Sciences Medication Adherence Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10 Takeda
2.10.1 Business Overview
2.10.2 Medication Adherence Type and Applications
2.10.2.1 Type 1
2.10.2.2 Type 2
2.10.3 Takeda Medication Adherence Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.11 AbbVie
2.11.1 Business Overview
2.11.2 Medication Adherence Type and Applications
2.11.2.1 Type 1
2.11.2.2 Type 2
2.11.3 AbbVie Medication Adherence Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.12 Amgen
2.12.1 Business Overview
2.12.2 Medication Adherence Type and Applications
2.12.2.1 Type 1
2.12.2.2 Type 2
2.12.3 Amgen Medication Adherence Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.13 Teva
2.13.1 Business Overview
2.13.2 Medication Adherence Type and Applications
2.13.2.1 Type 1
2.13.2.2 Type 2
2.13.3 Teva Medication Adherence Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.14 Lilly
2.14.1 Business Overview
2.14.2 Medication Adherence Type and Applications
2.14.2.1 Type 1
2.14.2.2 Type 2
2.14.3 Lilly Medication Adherence Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.15 Bristol-Myers Squibb
2.15.1 Business Overview
2.15.2 Medication Adherence Type and Applications
2.15.2.1 Type 1
2.15.2.2 Type 2
2.15.3 Bristol-Myers Squibb Medication Adherence Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.16 Bayer
2.16.1 Business Overview
2.16.2 Medication Adherence Type and Applications
2.16.2.1 Type 1
2.16.2.2 Type 2
2.16.3 Bayer Medication Adherence Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.17 Novo Nordisk
2.17.1 Business Overview
2.17.2 Medication Adherence Type and Applications
2.17.2.1 Type 1
2.17.2.2 Type 2
2.17.3 Novo Nordisk Medication Adherence Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.18 Astellas
2.18.1 Business Overview
2.18.2 Medication Adherence Type and Applications
2.18.2.1 Type 1
2.18.2.2 Type 2
2.18.3 Astellas Medication Adherence Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.19 Boehringer Ingelheim
2.19.1 Business Overview
2.19.2 Medication Adherence Type and Applications
2.19.2.1 Type 1
2.19.2.2 Type 2
2.19.3 Boehringer Ingelheim Medication Adherence Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.20 Actavis
2.20.1 Business Overview
2.20.2 Medication Adherence Type and Applications
2.20.2.1 Type 1
2.20.2.2 Type 2
2.20.3 Actavis Medication Adherence Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Medication Adherence Market Competition, by Manufacturer
3.1 Global Medication Adherence Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Medication Adherence Revenue and Market Share by Manufacturer (2016-2017)
3.3 Global Medication Adherence Price by Manufacturer (2016-2017)
3.4 Market Concentration Rate
3.4.1 Top 3 Medication Adherence Manufacturer Market Share
3.4.2 Top 5 Medication Adherence Manufacturer Market Share
3.5 Market Competition Trend
4 Global Medication Adherence Market Analysis by Regions
4.1 Global Medication Adherence Sales, Revenue and Market Share by Regions
4.1.1 Global Medication Adherence Sales by Regions (2012-2017)
4.1.2 Global Medication Adherence Revenue by Regions (2012-2017)
4.2 North America Medication Adherence Sales and Growth (2012-2017)
4.3 Europe Medication Adherence Sales and Growth (2012-2017)
4.4 Asia-Pacific Medication Adherence Sales and Growth (2012-2017)
4.5 South America Medication Adherence Sales and Growth (2012-2017)
4.6 Middle East and Africa Medication Adherence Sales and Growth (2012-2017)
5 North America Medication Adherence by Countries, Type, Application and Manufacturers
5.1 North America Medication Adherence Sales, Revenue and Market Share by Countries
5.1.1 North America Medication Adherence Sales by Countries (2012-2017)
5.1.2 North America Medication Adherence Revenue by Countries (2012-2017)
5.1.3 USA Medication Adherence Sales and Growth (2012-2017)
5.1.4 Canada Medication Adherence Sales and Growth (2012-2017)
5.1.5 Mexico Medication Adherence Sales and Growth (2012-2017)
5.2 North America Medication Adherence Sales and Revenue (value) by Manufacturers (2016-2017)
5.2.1 North America Medication Adherence Sales by Manufacturers (2016-2017)
5.2.2 North America Medication Adherence Revenue by Manufacturers (2016-2017)
5.3 North America Medication Adherence Sales by Type (2012-2017)
5.4 North America Medication Adherence Sales by Application (2012-2017)
6 Europe Medication Adherence by Countries, Type, Application and Manufacturers
6.1 Europe Medication Adherence Sales, Revenue and Market Share by Countries
6.1.1 Europe Medication Adherence Sales by Countries (2012-2017)
6.1.2 Europe Medication Adherence Revenue by Countries (2012-2017)
6.1.3 Germany Medication Adherence Sales and Growth (2012-2017)
6.1.4 UK Medication Adherence Sales and Growth (2012-2017)
6.1.5 France Medication Adherence Sales and Growth (2012-2017)
6.1.6 Russia Medication Adherence Sales and Growth (2012-2017)
6.1.7 Italy Medication Adherence Sales and Growth (2012-2017)
6.2 Europe Medication Adherence Sales and Revenue (value) by Manufacturers (2016-2017)
6.2.1 Europe Medication Adherence Sales by Manufacturers (2016-2017)
6.2.2 Europe Medication Adherence Revenue by Manufacturers (2016-2017)
6.3 Europe Medication Adherence Sales by Type (2012-2017)
6.4 Europe Medication Adherence Sales by Application (2012-2017)
7 Asia-Pacific Medication Adherence by Countries, Type, Application and Manufacturers
7.1 Asia-Pacific Medication Adherence Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Medication Adherence Sales by Countries (2012-2017)
7.1.2 Asia-Pacific Medication Adherence Revenue by Countries (2012-2017)
7.1.3 China Medication Adherence Sales and Growth (2012-2017)
7.1.4 Japan Medication Adherence Sales and Growth (2012-2017)
7.1.5 Korea Medication Adherence Sales and Growth (2012-2017)
7.1.6 India Medication Adherence Sales and Growth (2012-2017)
7.1.7 Southeast Asia Medication Adherence Sales and Growth (2012-2017)
7.2 Asia-Pacific Medication Adherence Sales and Revenue (value) by Manufacturers (2016-2017)
7.2.1 Asia-Pacific Medication Adherence Sales by Manufacturers (2016-2017)
7.2.2 Asia-Pacific Medication Adherence Revenue by Manufacturers (2016-2017)
7.3 Asia-Pacific Medication Adherence Sales by Type (2012-2017)
7.4 Asia-Pacific Medication Adherence Sales by Application (2012-2017)
8 South America Medication Adherence by Countries, Type, Application and Manufacturers
8.1 South America Medication Adherence Sales, Revenue and Market Share by Countries
8.1.1 South America Medication Adherence Sales by Countries (2012-2017)
8.1.2 South America Medication Adherence Revenue by Countries (2012-2017)
8.1.3 Brazil Medication Adherence Sales and Growth (2012-2017)
8.1.4 Argentina Medication Adherence Sales and Growth (2012-2017)
8.1.5 Columbia Medication Adherence Sales and Growth (2012-2017)
8.2 South America Medication Adherence Sales and Revenue (value) by Manufacturers (2016-2017)
8.2.1 South America Medication Adherence Sales by Manufacturers (2016-2017)
8.2.2 South America Medication Adherence Revenue by Manufacturers (2016-2017)
8.3 South America Medication Adherence Sales by Type (2012-2017)
8.4 South America Medication Adherence Sales by Application (2012-2017)
9 Middle East and Africa Medication Adherence by Countries, Type, Application and Manufacturers
9.1 Middle East and Africa Medication Adherence Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Medication Adherence Sales by Countries (2012-2017)
9.1.2 Middle East and Africa Medication Adherence Revenue by Countries (2012-2017)
9.1.3 Saudi Arabia Medication Adherence Sales and Growth (2012-2017)
9.1.4 UAE Medication Adherence Sales and Growth (2012-2017)
9.1.5 Egypt Medication Adherence Sales and Growth (2012-2017)
9.1.6 Nigeria Medication Adherence Sales and Growth (2012-2017)
9.1.7 South Africa Medication Adherence Sales and Growth (2012-2017)
9.2 Middle East and Africa Medication Adherence Sales and Revenue (value) by Manufacturers (2016-2017)
9.2.1 Middle East and Africa Medication Adherence Sales by Manufacturers (2016-2017)
9.2.2 Middle East and Africa Medication Adherence Revenue by Manufacturers (2016-2017)
9.3 Middle East and Africa Medication Adherence Sales by Type (2012-2017)
9.4 Middle East and Africa Medication Adherence Sales by Application (2012-2017)
10 Global Medication Adherence Market Segment by Type
10.1 Global Medication Adherence Sales, Revenue and Market Share by Type (2012-2017)
10.1.1 Global Medication Adherence Sales and Market Share by Type (2012-2017)
10.1.2 Global Medication Adherence Revenue and Market Share by Type (2012-2017)
10.2 Cardiovascular Medication Adherence Sales Growth and Price
10.2.1 Global Cardiovascular Medication Adherence Sales Growth (2012-2017)
10.2.2 Global Cardiovascular Medication Adherence Price (2012-2017)
10.3 CNS Medication Adherence Sales Growth and Price
10.3.1 Global CNS Medication Adherence Sales Growth (2012-2017)
10.3.2 Global CNS Medication Adherence Price (2012-2017)
10.4 Diabetes Medication Adherence Sales Growth and Price
10.4.1 Global Diabetes Medication Adherence Sales Growth (2012-2017)
10.4.2 Global Diabetes Medication Adherence Price (2012-2017)
10.5 Other Sales Growth and Price
10.5.1 Global Other Sales Growth (2012-2017)
10.5.2 Global Other Price (2012-2017)
11 Global Medication Adherence Market Segment by Application
11.1 Global Medication Adherence Sales Market Share by Application (2012-2017)
12 Medication Adherence Market Forecast (2017-2022)
12.1 Global Medication Adherence Sales, Revenue and Growth Rate (2017-2022)
12.2 Medication Adherence Market Forecast by Regions (2017-2022)
12.2.1 North America Medication Adherence Market Forecast (2017-2022)
12.2.2 Europe Medication Adherence Market Forecast (2017-2022)
12.2.3 Asia-Pacific Medication Adherence Market Forecast (2017-2022)
12.2.4 South America Medication Adherence Market Forecast (2017-2022)
12.2.5 Middle East and Africa Medication Adherence Market Forecast (2017-2022)
12.3 Medication Adherence Market Forecast by Type (2017-2022)
12.4 Medication Adherence Market Forecast by Application (2017-2022)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Analyst Introduction
15.3 Data Source
(North America, Europe and Asia-Pacific, South America, Middle East and Africa) Medication Adherence
(North America, Europe and Asia-Pacific, South America, Middle East and Africa) Medication Adherence
×